Niramai

NIRAMAI Health Analytix develops Thermalytix, an AI-based medical device for detecting early-stage breast cancer using thermal imaging. The screening is non-invasive, radiation-free and contactless, and the company states it works regardless of age or breast density for women aged 18 and above. Portable equipment suits primary clinics, hospitals, outreach programmes and screening camps. Related products include the SMILE 100 thermal imaging system, the Mythri mobile screening device and Thermalytix Edge AI for point-of-care use.

• AI-based thermal imaging analysis for early breast cancer detection
• Non-invasive, radiation-free, contactless screening
• Portable equipment for clinics and screening camps
• Thermalytix Edge AI running locally at the point of care
• Mythri mobile device for low-cost triage and risk assessment